share_log

EF Hutton Initiates Coverage On Citius Pharma With Buy Rating, Announces Price Target of $6

EF Hutton Initiates Coverage On Citius Pharma With Buy Rating, Announces Price Target of $6

EF赫頓開始對Citius Pharma進行買入評級,並公佈了6美元的目標價。
Benzinga ·  07/15 09:44

EF Hutton analyst Jason Kolbert initiates coverage on Citius Pharma (NASDAQ:CTXR) with a Buy rating and announces Price Target of $6.

EF胡頓分析師Jason Kolbert對Citius Pharma(納斯達克:CTXR)給予買入評級,並宣佈6美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論